Xenon製藥 XENE 深 滬
等待開盤 09-25 09:30:00 美东时间
37.135
+0.575
+1.57%
華盛通- 最 高37.415
- 今 開36.50
- 成交量 148.34万股
- 最 低 36.07
- 昨 收 36.56
- 總市值 35.96亿
- 52周最高 72.66
- 市盈率 靜 --
- 換手率 1.53%
- 52周最低 36.07
- 委 比 -65.43%
- 總股本 9684.04万
- 歷史最高 72.66
- 量 比 0.33
- 振 幅 3.68%
- 歷史最低 2.10
- 每 手 1
- 風險率 9.19%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股前瞻 | 中美高层会谈释放积极信号！纳指期货升逾1%；比特币再度站上8.5万美元；英特尔盘前升逾5%，布局先进封装剑指光通信赛道
中美高层会谈释放积极信号！纳指期货升逾1%；比特币再度站上8.5万美元，小摩称其升势比黄金“更强”；英特尔盘前升逾5%，布局先进封装剑指光通信赛道>>
09-21 20:14
美股大行评级 | 奈飞遭看淡至57美元！现价仍有两成下行空间；Xenon制药遭多家机构降目标价，最低看至46美元
今日重点评级关注：康托·菲茨杰拉德：维持Abeona Therapeutics"超配"评级，目标价从28美元升至30美元；HC Wainwright & Co.：维持Oculis Holding"买入"评级，目标价从26美元升至39美元
09-21 16:25
9月21日财经早餐：油价走低缓解通胀担忧，金价获支撑再战4400关口，美方称准备与伊朗谈判
汇通财经APP讯——周一（北京时间9月21日）亚市早盘，现货黄金交投于4373美元/盎司附近，金价受益于油价走低缓解了市场对通胀压力持续的担忧，日内或再决战...
09-21 07:20
Xenon downgraded at Deutsche Bank after pause in depression trials
Xenon Pharmaceuticals (XENE) fell 30% to reach its lowest level since November after the company paused enrollment in Phase 3 depression trials for its lead asset, azetukalner, following safety concer...
09-19 01:27
Xenon Stock Reaction Is Overblown: Analyst
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) submitted a New Drug Application to the U.S. Food and Drug Administration for its investigational drug azetukalner to treat focal seizures. Simultaneously, the neuroscience-focused biopharmaceutical company announced a voluntary pause on new patient enrollmen...
09-18 23:14
This Netflix Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. BMO Capital analyst Tamy Chen downgraded Magna International Inc (NYSE:MGA) from Outperform to Ma...
09-18 20:48
Market-Moving News for September 18th
TCRT: 69% | Alaunos Therapeutics On Thursday Filed Patent Application "Identification Of Neoantigen-Reactive T Cell Receptors" MEDS: 24% | DataMeds AI Settles Litigation Related To Outstanding Debt And Receivables Related To The 2023 Wellgistics Agreement; Company Retired ~364,099 MEDS Shares And ...
09-18 19:24
Baird Maintains Outperform on Xenon Pharmaceuticals, Lowers Price Target to $90
Baird analyst Brian Skorney maintains Xenon Pharmaceuticals (NASDAQ:XENE) with a Outperform and lowers the price target from $97 to $90.
09-18 19:07
Xenon Pharmaceuticals (XENE) Shares Fall 25% After Hours: Here's Why
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) shares fell 25.39% to $42.79 in after-hours trading Thursday after the company announced a temporary pause in enrollment for new patients in its ongoing psychiatry studies. Xenon Pharmaceuticals is a neuroscience-focused biopharmaceutical company developing t...
09-18 14:04
Stocks to watch on Thursday after hours: INTA, XENE, PXED
Wall Street rebounded Thursday after Wednesday’s selloff, which followed the Federal Reserve’s first rate hike since 2023. The blue-chip Dow (DJI) closed +0.6%, the benchmark S&P 500 (SP500) added +1....
09-18 04:51
